Back to Archived Journals » Hypoxia » Volume 5
Original Research
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,304 | Dovepress* | 7,998+ | 793 | 8,791 | |
PubMed Central* | 306 | 103 | 409 | ||
Totals | 8,304 | 896 | 9,200 | ||
*Since 23 May 2017 |
View citations on PubMed Central and Google Scholar